Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
Aurora Cannabis is expanding its global medical portfolio with new dried flower, pre-roll, and pastille products launching in Canada, Germany, Poland, and Australia. The rollout, scheduled through June, leverages the company's GMP-certified network to meet patient and prescriber demand in regulated international markets.
Key figures
- German products
- 2
- Polish products
- 2
- Canadian products
- 4
- Australian products
- 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.